Prosecution Insights
Last updated: October 02, 2026

Examiner: HOBAN, MELISSA A

Tech Center 3700 • Art Units: 3738 3774

This examiner grants 63% of resolved cases

Analysis

Melissa A Hoban has 625 resolved cases in Tech Center 3700 and Art Unit 3738. The allowance rate is 62.7%. This 62.7% rate suggests a positive outlook for applicants seeking patent protection. The 625 resolved cases provide a substantial data set for identifying clear trends in her prosecution history in Tech Center 3700.

The interview lift of 13.6% suggests that interviews can help advance prosecution. This 13.6% lift indicates that direct communication can help resolve technical issues or misunderstandings. For the 625 cases resolved, the 13.6% lift serves as a strategic incentive for practitioners to engage the examiner. It complements the 62.7% allowance rate by offering a clear path to improve outcomes in Art Unit 3738.

The median days to allowance is 1419. This 1419-day duration provides a clear timeline expectation for the prosecution process. Applicants should factor this 1419-day metric into their planning. The combination of a 62.7% allowance rate and a 1419-day median pendency suggests a productive environment for the 625 cases handled by this examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

62.8%
Allow Rate
-7.2% vs TC avg
674
Total Applications
+13.7%
Interview Lift
1418
Avg Prosecution Days
Based on 626 resolved cases, 2023–2026

Rejection Statute Breakdown

1.3%
§101 Eligibility
23.5%
§102 Novelty
45.1%
§103 Obviousness
24.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17149527 FEMORAL AND HUMERAL STEM GEOMETRY AND IMPLANTATION METHOD FOR ORTHOPEDIC JOINT RECONSTRUCTION Non-Final OA HOWMEDICA OSTEONICS CORP.
18594465 MODULAR ACETABULAR SURGICAL IMPLANT ASSEMBLY Non-Final OA DePuy Synthes Products, Inc.
18363936 MEDICAL CHAIN NET Non-Final OA Aesculap AG
18409074 MG ALLOY MESH REINFORCED POLYMER/ECM HYBRID SCAFFOLDS FOR CRITICAL-SIZED BONE DEFECT REGENERATION Non-Final OA UNIVERSITY OF CINCINNATI
18408750 ACTIVE SUBSTANCE APPLICATOR FOR A JOINT IMPLANT, AND JOINT IMPLANT HAVING AN ACTIVE SUBSTANCE APPLICATOR Non-Final OA Waldemar Link GmbH & Co. KG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month